7-80135161-A-G
Position:
Variant summary
Our verdict is Pathogenic. Variant got 10 ACMG points: 10P and 0B. PVS1PM2
The NM_002069.6(GNAI1):āc.1A>Gā(p.Met1?) variant causes a start lost change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000073 in 1,368,986 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: not found (cov: 32)
Exomes š: 7.3e-7 ( 0 hom. )
Consequence
GNAI1
NM_002069.6 start_lost
NM_002069.6 start_lost
Scores
7
7
2
Clinical Significance
Conservation
PhyloP100: 8.41
Genes affected
GNAI1 (HGNC:4384): (G protein subunit alpha i1) Guanine nucleotide binding proteins are heterotrimeric signal-transducing molecules consisting of alpha, beta, and gamma subunits. The alpha subunit binds guanine nucleotide, can hydrolyze GTP, and can interact with other proteins. The protein encoded by this gene represents the alpha subunit of an inhibitory complex. The encoded protein is part of a complex that responds to beta-adrenergic signals by inhibiting adenylate cyclase. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jan 2012]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 10 ACMG points.
PVS1
Start lost variant, no new inframe start found.
PM2
Very rare variant in population databases, with high coverage;
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 genomes
Cov.:
32
GnomAD4 exome AF: 7.30e-7 AC: 1AN: 1368986Hom.: 0 Cov.: 29 AF XY: 0.00 AC XY: 0AN XY: 679560
GnomAD4 exome
AF:
AC:
1
AN:
1368986
Hom.:
Cov.:
29
AF XY:
AC XY:
0
AN XY:
679560
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome Cov.: 32
GnomAD4 genome
Cov.:
32
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Developmental disorder Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Department of Genetics, Rouen University Hospital, Normandy Center for Genomic and Personalized Medicine | Feb 07, 2024 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Pathogenic
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Pathogenic
D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;.
Eigen
Uncertain
Eigen_PC
Benign
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
.;.;.;.;.;.;.;.;.;.;.;.;.;.;D;D
M_CAP
Pathogenic
D
MetaRNN
Pathogenic
D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D
MetaSVM
Uncertain
D
PROVEAN
Uncertain
.;.;.;.;.;.;.;.;.;.;D;.;.;N;.;.
REVEL
Pathogenic
Sift
Pathogenic
.;.;.;.;.;.;.;.;.;.;.;.;.;D;.;.
Sift4G
Uncertain
.;.;.;.;.;.;.;.;.;.;.;.;.;D;.;.
Polyphen
P;P;P;P;P;P;P;P;P;P;P;P;P;P;P;.
Vest4
0.89
MutPred
Loss of phosphorylation at S6 (P = 0.1699);Loss of phosphorylation at S6 (P = 0.1699);Loss of phosphorylation at S6 (P = 0.1699);Loss of phosphorylation at S6 (P = 0.1699);Loss of phosphorylation at S6 (P = 0.1699);Loss of phosphorylation at S6 (P = 0.1699);Loss of phosphorylation at S6 (P = 0.1699);Loss of phosphorylation at S6 (P = 0.1699);Loss of phosphorylation at S6 (P = 0.1699);Loss of phosphorylation at S6 (P = 0.1699);Loss of phosphorylation at S6 (P = 0.1699);Loss of phosphorylation at S6 (P = 0.1699);Loss of phosphorylation at S6 (P = 0.1699);Loss of phosphorylation at S6 (P = 0.1699);Loss of phosphorylation at S6 (P = 0.1699);Loss of phosphorylation at S6 (P = 0.1699);
MVP
0.99
ClinPred
D
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.